High-density lipoprotein, or "good"cholesterol
21 of 22 providers
Lipid Panel / Cardiovascular Health
Men:>40 mg/dL, Women:>50 mg/dL, Optimal:>60 mg/dL
HDL Cholesterol (High-Density Lipoprotein Cholesterol) is often called "good cholesterol"because it transports cholesterol from peripheral tissues back to the liver for excretion—a process called reverse cholesterol transport. HDL particles also have anti-inflammatory, antioxidant, and anti-thrombotic properties that protect against atherosclerosis.
Normal HDL is >40 mg/dL in men and >50 mg/dL in women, with >60 mg/dL considered protective. Historically, HDL was thought to be causally protective—the higher the better. However, recent trials show raising HDL with medications (niacin, CETP inhibitors) does not reduce cardiovascular events, questioning HDL's causal role. The relationship may be more complex:HDL is a marker of metabolic health rather than a therapeutic target.
HDL functionality matters more than quantity. Dysfunctional HDL (from inflammation, diabetes, smoking) may paradoxically promote atherosclerosis despite normal or high levels. This explains why some people with high HDL still have heart disease, and why raising HDL with drugs failed to reduce events. HDL cholesterol efflux capacity (ability to remove cholesterol from macrophages) is a better predictor of cardiovascular risk than HDL level, though not widely available clinically.
| Range Type | Level | Significance |
|---|---|---|
| Protective | >60 mg/dL | Associated with reduced cardiovascular risk. Each 1 mg/dL increase in HDL correlates with 2-3% lower cardiovascular risk in observational studies. Reflects healthy lifestyle:regular exercise, lean body mass, Mediterranean diet, no smoking. |
| Adequate | 40-60 mg/dL (men), 50-60 mg/dL (women) | Acceptable range but not optimal. Consider lifestyle interventions to raise HDL:aerobic exercise (most effective, raises HDL 3-9%), weight loss, smoking cessation, moderate alcohol (1-2 drinks daily raises HDL 3-5 mg/dL but also increases triglycerides). |
| Low (Increased CV Risk) | <40 mg/dL (men), <50 mg/dL (women) | Low HDL increases cardiovascular risk 50-100%. Often part of metabolic syndrome with high triglycerides, abdominal obesity, insulin resistance. Focus on weight loss, exercise, treating insulin resistance. Medications to raise HDL (niacin, fibrates) don't reduce cardiovascular events—focus on lowering LDL instead. If triglycerides >200 mg/dL, fibrate may help both. |
| Very Low (High Risk) | <20 mg/dL | Very high cardiovascular risk (2-3x normal). Indicates severe metabolic dysfunction, often with diabetes, obesity, severe hypertriglyceridemia (>500 mg/dL). Requires aggressive lifestyle modification and LDL lowering. Check for tangier disease (genetic HDL deficiency) if HDL <10 mg/dL. |
Aerobic exercise:150-300 min/week moderate to vigorous intensity. Raises HDL 3-9 mg/dL (5-15%). Running, cycling, swimming most effective
High-intensity interval training:May increase HDL more than moderate intensity. 20-30 min sessions 2-3x/week
Resistance training:Weight lifting 2-3x/week modestly raises HDL, especially combined with aerobic exercise
Duration matters:HDL increase proportional to exercise duration. Need consistent 3-4 months to see maximal HDL rise
Mechanism:Exercise increases lipoprotein lipase and hepatic lipase, enzymes that remodel lipoproteins and raise HDL
Weight loss:Each 6 lbs lost raises HDL ~1 mg/dL. Effect most pronounced if overweight/obese
Visceral fat reduction:Abdominal fat lowers HDL more than subcutaneous fat. Measure waist circumference—target <40"men, <35"women
Build muscle mass:Higher lean body mass associated with higher HDL. Resistance training helps
Avoid crash dieting:Severe caloric restriction transiently lowers HDL. Gradual weight loss (1-2 lbs/week) preferred
Maintain weight loss:HDL improvements sustained only if weight loss maintained
Mediterranean diet:Olive oil, nuts, fish, vegetables. Raises HDL 3-5 mg/dL and improves HDL function
Omega-3 fatty acids:2-4g EPA+DHA daily. Modest HDL increase (2-3 mg/dL) but improves particle function
Monounsaturated fats:Olive oil, avocados, nuts. Replace saturated fats with MUFA to raise HDL
Avoid trans fats:Trans fats lower HDL. Eliminate partially hydrogenated oils
Moderate alcohol:1-2 drinks daily raises HDL 3-5 mg/dL. However, also raises triglycerides. Not recommended solely to raise HDL
Purple/blue foods:Anthocyanins in berries, red wine, purple vegetables may improve HDL function
Improve insulin sensitivity:Low HDL often reflects insulin resistance. Metformin 1000-2000 mg daily, weight loss, exercise improve insulin sensitivity and raise HDL
Treat diabetes:Optimal glycemic control (HbA1c <7%) improves HDL. GLP-1 agonists and SGLT2 inhibitors modestly increase HDL
Lower triglycerides:TG >150 mg/dL suppresses HDL. Reduce simple carbs, lose weight. If TG >200 mg/dL, fibrate therapy raises HDL 10-20%
Thyroid optimization:Hypothyroidism lowers HDL. Ensure TSH 0.5-2.5 mIU/L
Testosterone:Low testosterone in men associated with low HDL. Consider evaluation if HDL <35 mg/dL with low muscle mass
Smoking cessation:Quitting raises HDL 3-10 mg/dL within weeks. Smoking makes HDL dysfunctional even if level is normal
Adequate sleep:7-9 hours nightly. Sleep deprivation lowers HDL
Stress management:Chronic stress lowers HDL via cortisol. Meditation, mindfulness help
Medications that lower HDL:Beta-blockers, thiazide diuretics, anabolic steroids. Discuss alternatives with doctor if HDL low
Don't use niacin:Niacin raises HDL 15-35% but doesn't reduce cardiovascular events and causes flushing, hyperglycemia. No longer recommended for low HDL
Framingham and other cohort studies show inverse relationship between HDL and cardiovascular risk. Each 1 mg/dL increase in HDL correlates with 2-3% lower cardiovascular risk. HDL <40 mg/dL in men and <50 mg/dL in women approximately doubles cardiovascular risk. However, this is association, not proven causation.
Source:Gordon DJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Circulation. 1989;79(1):8-15.
Multiple trials of HDL-raising therapies (niacin, CETP inhibitors) failed to reduce cardiovascular events despite successfully raising HDL 20-40%. AIM-HIGH, HPS2-THRIVE (niacin) and dal-OUTCOMES (dalcetrapib CETP inhibitor) all showed no benefit. This proved raising HDL pharmacologically doesn't reduce cardiovascular risk—HDL is a marker, not a target.
Source:Boden WE, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255-2267.
HDL cholesterol efflux capacity (ability to remove cholesterol from macrophages) predicts cardiovascular events independent of HDL level. Patients with high efflux capacity have lower risk even with low HDL, while those with low efflux have higher risk despite high HDL. This suggests HDL function is more important than quantity, but efflux testing is not widely available.
Source:Rohatgi A, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383-2393.
Meta-analyses of exercise interventions show aerobic exercise raises HDL 3-9% (typically 2-8 mg/dL). Effect is dose-dependent—more exercise, greater HDL increase. Combination of aerobic and resistance training is most effective. HDL increase occurs within 3-4 months and requires ongoing exercise to maintain. This makes exercise the most effective HDL-raising intervention.
Source:Kodama S, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol:a meta-analysis. Arch Intern Med. 2007;167(10):999-1008.
HDL <40 mg/dL is a component of metabolic syndrome and strongly associated with insulin resistance. Low HDL in metabolic syndrome reflects underlying metabolic dysfunction rather than being causal. Treatment focuses on weight loss, exercise, and treating insulin resistance (metformin, GLP-1 agonists) which secondarily raise HDL. Fibrates raise HDL but don't reduce cardiovascular events unless triglycerides >200 mg/dL.
Source:Grundy SM, et al. Diagnosis and management of the metabolic syndrome:an AHA/NHLBI scientific statement. Circulation. 2005;112(17):2735-2752.
| Provider | Includes | Annual Cost | Biomarkers |
|---|---|---|---|
| ✓ | $199 | 100+ (150 with ratios) | |
| ✓ | $349 | 65 | |
| ✓ | $398 | 30+ | |
| ✓ | $486 | 40+ | |
| ✓ | $468 | 83 | |
| ✓ | $349 | 100+ | |
| ✓ | $680 | 54 | |
| ✓ | $365 | 100+ | |
| ✓ | $250 | 65 | |
| ✓ | $495 | 70+ | |
| ✓ | $895 | 100+ | |
| ✓ | $1950 | 150+ | |
| — | $399 | 100+ | |
| — | $Varies | 75+ | |
| ✓ | $190 | 100+ | |
| ✓ | $99 | 50 | |
| ✓ | $125 | 60 | |
| ✓ | $199 | 50 | |
| ✓ | $499 | 120+ | |
| ✓ | $4188 | 80+ | |
| ✓ | $375 | 85 | |
| ✓ | $700 | 129 |
21 providers include this biomarker in their panels
This information is for educational purposes only and is not medical advice. Always consult with a qualified healthcare provider about your specific health needs.